frenzy, page-32

re: sirtex goal: $5 then $8 -$9 With Bioshares reiterating buy recommendation, Huntley backing, and Hunter Hall telling clients they are very glad to be patient and have used last 18 mos and currently to buy shares adding to their very large position , there are still most of the analysts who have no idea ofwhat is happening as they left analyzing co after Sirtex rejected Cepaholon $4.85 bid over 2yrs ago.As these backwards analysts start to realize big growth story from all the reasons I previously cited they will start to recommend shares probaly after sp is near $4 saying it is worth $8 or $9 currently based on conservative $ 72 cents earnings estimate for 2008.Then as gold and oil investors realize that gold and oil may be in consolidation phase after rather large gains over the last year , they will realize that biotechs are in early bullphase and redeploy someof their funds into high growth biotechs with FDAapproved products that are profitable like Sirtex. This will accenuate move up as the float is only about 8 million shares and the move upwill be quicker than anticipated.My opinion only after being in the industry a while.Do Your own work. Either way through the growth play or potential acqiusition by a bio-pharma partner, with Dr Gray having 47 million dollars of his net worth which probably represents most of his assets invested in the company, I feel comfortable being on his side as he will do best for himself and us shareholders.